Multiple equities research analysts have issued reports raising price target expectations for HCA Healthcare Inc.

Analysts at RBC Capital have raised the price target of the company's shares to $482 from $449.

Barclays boosted its price target to $494 from $445 and gave the company an "overweight" rating in a research report on Oct. 27. That same day, Raymond James Financial set a $525 price target on shares of HCA Healthcare in a research report, according to marketbeat.com

The forecasts follow HCA’s strong third quarter results, reported on Oct. 24 and that saw some metric beat expectations.

As reported by the Post , HCA Healthcare lifted its yearly profit and revenue forecasts based on third quarter earnings that significantly exceeded analysts' expectations.

The company poste

See Full Page